Supraventricular tachycardias (atrioventricular reentrant tachycardia due to accessory pathways and atrioventricular nodal reentrant tachycardia) are common in children. During the past decade, transcatheter radiofrequency ablation (RFA) of supraventricular tachycardia in children became a method of choice due to its safety and effectiveness \[[@CR11]\].

Alterations of heart rate (HR) and the presence of persistent, innapropriate sinus tachycardia, particularly after atrioventricular (AV) node slow-pathway ablation, have been reported for a variable percentage of patients \[[@CR8]--[@CR10]\]. It is suggested that disturbances of autonomic tone may be a contributing factor \[[@CR9]\].

It remains unclear whether increased HR and frequent epizodes of sinus tachycardia after RFA have any influence on the systolic and diastolic function of the heart. Current conventional echocardiographic parameters assess only global left ventricular function, which are not always sensitive. Even in patients with symptoms of heart failure, they may remain within normal limits.

Assessment of regional atrial and ventricular function may provide important diagnostic information. The development of new echocardiographic techniques such as two-dimensional (2D) speckle-tracking echocardiography (2D STE) allows assessment of regional systolic and diastolic heart function, atrial and ventricular deformation parameters, speckle tracking-derived velocity, strain (ε), and strain rate (SR) \[[@CR2], [@CR4], [@CR18]\].

Strain rate, which reflects the rate of myocardial deformation, has been developed by estimating the spatial gradients in myocardial velocities, whereas ε, its integral, determines the total amount of local tissue deformation \[[@CR4], [@CR17]\]. Both are independent of overall heart motion, cardiac rotation, or motion induced by contraction in adjacent myocardial segments and thus are the true measure of local deformation. There are no data on subclinical changes in the systolic and diastolic functions of the heart in children who have undergone transcatheter RFA.

This study was designed to assess HR variability (HRV) using ambulatory Holter monitoring, AV node conduction determined by electrophysiologic transesophageal examination, and ventricular and atrial function determined by 2D STE in children at late follow-up assessment after RFA of the AV node slow pathway.

Materials and Methods {#Sec1}
=====================

Study Population {#Sec2}
----------------

The study group consisted of 42 subjects including 20 healthy children (control group) (10 boys) with a mean age of 16.3 ± 1.6 years and 22 children (11 boys) with mean age of 16.59 ± 2.44 years who underwent successful AV node slow-pathway RFA 2 to 5 years previously (RFA group). During the period 2000--2005, RFA of the AV node slow pathway was performed for 40 children due to typical AV nodal reentrant tachycardia. For 25 patients, modification of the slow pathway was performed, and for 15 patients, slow-pathway ablation was completed. The mean procedure time was 215 ± 64 min, and the mean number of applications was 4 or 5. Only two minor complications (5%), hematoma and phlebitis, were reported.

At the late follow-up assessment, 22 children were investigated (20 for whom the slow pathway was modified and 2 for whom it was completely eliminated). The remaining 18 children refused to participate in the study or were older than 18 years. Before treatment, the children experienced paroxysms of tachycardia with a mean duration of 57 ± 41.04 min. The mean HR during the paroxysm was 196.6 ± 33.1 beats per minute (bpm), and the mean rate of paroxysms was 3.25 ± 1.56 per month.

At the study time (late follow-up assessment after RFA), all the children were free of paroxysms except for eight children who experienced transient palpitations and did not use any medications. No signs of heart disease were detected by physical examination, electrocardiogram (ECG), or transthoracic conventional echocardiography. The healthy children (control group) had no complaints, no symptoms of heart failure, no history of cardiac rhythm disturbance, and no evidence of heart disease by physical examination, ECG, transthoracic echocardiography (no signs of left ventricular \[LV\] or right ventricular \[RV\] hypertrophy, valvular disease, or wall motion abnormalities), and they did not use any medications.

The two groups did not differ significantly in terms of age, body surface area, or body mass index (Table [2](#Tab2){ref-type="table"}). The control group underwent 12-lead ECG ambulatory Holter monitoring and echocardiographic investigation. Due to discomfort of the electrophysiologic study, the electrophysiologic transesophageal investigation was not performed for the control group. The RFA group underwent 12-lead ECG ambulatory Holter monitoring 1 to 2 days before RFA. Subsequently, late after RFA, they underwent echocardiographic and electrophysiologic transesophageal investigations.

The study protocol was approved by the Ethics Commitee of the Kaunas University of Medicine. Informed consent was obtained before the study from all the patients or their parents.

Electrophysiologic Transesophageal Examination of the Heart Conductive System {#Sec3}
-----------------------------------------------------------------------------

This examination was performed for the RFA patients. The patients were examined while lying with a multicontact electrode polyurethane electrode diagnostic multicontact (PEDM) inserted into the esophagus. One pair of electrodes was used for the registration of transesophageal ECG, and another pair was used for the transesophageal stimulation. A computerized electrophysiologic system (CardioLab; GE, Milwaukee, WI, USA) was used for transesophageal ECG recordings and protocols, and the electrophysiologic MedSystems computerized stimulator EP-4 (West Berlin, NJ, USA) was used for cardiac pacing.

The following parameters were measured during the examination: ECG, sinus cycle length, PR interval, AV conduction, AV conduction time, prolongation of AV conduction time by a jump (≥50 ms, representing the manifestation of antegrade dual AV nodal pathways) using atrial incremental pacing, and the AV node refractory period (ERP), estimated by programmed atrial pacing, with coupling intervals decreased 10 ms until the AV node refractory period occurred. These parameters were compared with parameters obtained during diagnostic preablation electrophysiologic transesophageal examination.

Holter Monitoring and HR Variability Analysis {#Sec4}
---------------------------------------------

The examination was performed on an ambulatory basis using the commercially available MemoPort 2000/4000 software package system (Marquette Hellige Company, Northamptonshire, UK). Holter's monitor SRPL-10 (Northamptonshire, UK) (storing data on the hard disc) was used for 24-h ECG registration. Holter's monitor recorded three bipolar ECGs. The data then were transferred to the computer, and the analysis of the results was performed.

The following parameters of the recorded ECG were evaluated: minimal rate of the heart contractions (bpm) recorded during 24 h (HR min), mean rate of the heart contractions (bpm) recorded during 24 h (HR mean), and maximal rate of the heart contractions (bpm) recorded during 24 h HR maximum (HR max).

The parameters of HRV were calculated in compliance with the recommendations of the American Heart Association and the European Society of Cardiology \[[@CR1]\]. The analysis of HRV was performed when the range of ECG signals exceeded 100 Hz. The ECG record was filtered, and only normal QRS complexes were analyzed. The ectopic atrial and ventricular complexes and the episodes of pauses were excluded.

To avoid the influence of ectopic impulses, arrhythmias, and artifacts on HRV parameters, interpolation was performed. Gaps in the R-R sequence due to rejections of complexes were filled in with automatically calculated R-R intervals during interpolation. The chosen quantified frequency of the R-R sequence was 292 ms. The parabolic method was used for the de-trending. The Fourje fast-transformation method was used to calculate frequency parameters.

The following parameters were used for HRV analysis: time-domain indices: standard deviation of all normal sinus RR intervals over 24 h (ms) (SDNN), percentage of the succesive normal sinus RR intervals exceeding 50 ms (%) (pNN50), and root mean square of the successive normal sinus RR interval difference (ms) (rMSSD). The frequency domain indices were the low-frequency component (LFC) (frequency range, 0.04--0.15 Hz), the high-frequency component (HFC) (frequency range, 0.15--0.40 Hz), and the total spectrum. The HR and HRV parameters for the RFA patients, obtained during the late postablation period, were compared with the preablation 24-h Holter recording data.

Conventional Echocardiography {#Sec5}
-----------------------------

Echocardiographic technique and calculations of morphometric parameters were performed in accordance with the recommendations of the American Society of Echocardiography 2005 \[[@CR12]\]. The biplane Simpson's rule was used for calculation of the LV ejection fraction. Maximum left atrium (LA) and right atrium (RA) volumes were obtained from the 2D frame just before mitral valve opening. Minimal LA and RA volumes were obtained from the smallest volumes seen after atrial contraction.

Automated Speckle-Tracking Imaging {#Sec6}
----------------------------------

For 2D STE analysis, we used Vivid 7 (GE Vingmed Ultrasound AS, Horten, Norway) equipment. Tissue harmonic images were scanned at long-axis apical four- and two-chamber views with the M3S probe (GE, Parallel Design Inc., Phoenix, AZ, USA). For analysis of LV, RV, LA, and RA long-axis function, apical four- and two-chamber views were used. The mean frame rate was 50 frames/s (range, 40--70 frames/s).

Digital loops were stored on the hard disc of the echocardiographic machine and transferred to a workstation (EchoPac PC, GE Vingmed Ultrasound AS, Horten, Norway) for offline analysis. A line was traced along the endocardium of the LV and RV at the frame where it was best defined. For atrial analysis, a line was drawn along the LA and RA endocardium when the atria were at their minimal volume after contraction. On the basis of this line, the computer automatically created a region of interest, and the software selected natural acoustic markers, moving with the tissue. Automatic frame-by-frame tracking of these markers during the heart cycle (2D STE method) yielded a measure of ε and SR at any point of the myocardium.

The LV was divided into six long-axis segments in each view. The RV was divided into basal and middle segments of the lateral wall. The RA was divided into two long-axis segments (annular and middle) of the lateral wall, and the LA was divided into four long-axis segments (annular and middle) of the septum, lateral, anterior, and inferior walls. The superior or "roof" region of the atria was excluded because this segment is rather stationary and makes no contribution to the atrial motion or active contraction.

Analysis of Regional Ventricular and Atrial Longitudinal Function: Strain and Strain Rate {#Sec7}
-----------------------------------------------------------------------------------------

The four-chamber view of the heart was analyzed offline using Echo PAC software to assess the ε and SR of the LV lateral wall, ventricular septum, RV lateral wall segments, RA lateral wall segments, atrial septum, and LA lateral wall segments. The apical two-chamber view was used to assess ε and SR of the LV inferior and anterior wall segments and the LA inferior and anterior wall segments using the 2D STE method.
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The EchoPac system calculates mean global ε and SR values for whole predefined LV and RV as well as LA and RA segments. Lengthening is positive and shortening is negative in this description. Atrial ε and SR values were measured during atrial contraction (time from the end of P-wave on ECG to mitral valve closure) and relaxation (time from mitral valve closure to aortic valve opening).

Statistical Analysis {#Sec8}
--------------------

Statistical analysis was performed with software SPPS version 14.0 (SPSS, Inc., Chicago, IL, USA). A *p* value of 0.05 or less was considered significant. All parametric data were expressed as mean ± standard deviation. When the distribution of variables was normal, Student's *t* test was used to compare quantitative sizes of two independent samples. The Mann--Whitney *U* test was used to compare non-normally distributed variables. For the normal distribution of quantitative dependent variables, Student's paired *t* test was used, and for non-normal distribution, the nonparametric Wilcoxon test was used. Chi-square tests were used to compare frequencies of qualitative variables. Spearman correlation coefficients were obtained to describe relations of parameters for different methods to evaluate the systolic and diastolic functions of the heart.

Intraobserver variability was determined by one observer repeating the measurements of STE in five randomly selected subjects 1 month later. Agreement between the measurements was evaluated by linear regression analysis using the correlation coefficient. In addition, Bland--Altman analysis was used to determine the bias and limits of agreement between the corresponding measurements. The significance of intertechnique biases was tested using paired *t* tests.

Results {#Sec9}
=======

Electrophysiologic Study {#Sec10}
------------------------

At the late follow-up evaluation, 8 of the 22 RFA children (36%) reported palpitations during their daily activity. The PR intervals were normal in all the RFA children. The sinus cycle length was shortened (644.4 ± 179.5 vs 736.6 ± 134 ms before ablation; *p* \< 0.05) and did not differ between the patients who had no complaints and those who experienced palpitations. At the follow-up evaluation, the slow pathway was observed for 20 patients (those who underwent modification of the slow pathway). Atrioventricular node supraventricular tachycardia could not be induced in any of the patients, and AV node conduction decreased significantly up to 146.3 ± 28.5 bpm compared with 190.9 ± 31.4 bpm before ablation (*p* \< 0.001). The AV node ERP was prolonged significantly up to 351.0 ± 82.1 ms compared with 248.3 ± 36.6 ms before ablation (*p* \< 0.001).

Holter Monitoring {#Sec11}
-----------------

### HR and HR Variability Analysis {#Sec12}

At late follow-up evaluation, HR mean and HR max were significantly increased, whereas pNN50, rMSSD, and HFC were significantly decreased in the RFA children compared with preablation and control data (Table [1](#Tab1){ref-type="table"}). Findings showed comparable SDNN between the groups. There were no changes in the LFC frequency domain or the total spectrum analysis. For the eight patients, who felt palpitations during their daily activity, the episodes of sinus tachycardia with an HR max of 144.3 ± 14.2 bpm and a mean duration of 1 to 2 min were registered on the Holter 24-h registrations.Table 1Heart rate and heart rate variability^a^ParameterRFA group (*n* = 22)*p* Value^b^Control group (*n* = 20)\**p* Value^c^PreablationPostablationHR min51.25 ± 5.053.59 ± 5.38NS51.75 ± 5.77NSHR mean71.07 ± 8.0778.72 ± 5.34\<0.00172.00 ± 9.230.002HR max131.71 ± 14.51143.91 ± 13.050.005132.5 ± 16.570.008SDNN (ms)159.36 ± 25.7149.78 ± 24.76NS163.85 ± 29.32NSpNN50 (%)26.64 ± 7.0320.63 ± 6.830.00626.20 ± 8.150.03rMSSD (ms)49.72 ± 11.6842.56 ± 12.580.03451.2 ± 14.50.01LFC (ms^2^)1,345.281224.83NS1,523.83NSHFC (ms^2^)1,032.59706.240.0071,014.650.027Total spectrum (ms^2^)6,134.446,045.16NS6,375.49NS*RFA* radiofrequency ablation, *HR min* minimal rate of the heart contractions (beats per minute \[bpm\]) recorded during 24 h, *NS* not significant by an independent two sampled test, *HR mean* mean rate of the heart contractions (bpm) recorded during 24 h, *HR max* maximal rate of the heart contractions (bpm) recorded during 24 h, *SDNN* standard deviation of all normal sinus RR intervals over 24 h, *pNN50* percentage of the succesive normal sinus RR intervals \>50 ms, *rMSSD* root mean square of the succesive normal sinus RR interval difference, *LFC* low-frequency component (frequency range, 0.04--0.15 Hz), *HFC* high-frequency component (frequency range, 0.15--0.40 Hz), total spectrum^a^Values are expressed as mean ± standard deviation^b^Preablation data compared with postablation data (values determined by paired Student's *t* test)^c^Postablation data compared with control group (values determined by unpaired Student's *t* test)

### Conventional Echocardiographic Parameters {#Sec13}

Conventional echocardiographic parameters are presented in Table [2](#Tab2){ref-type="table"}. The two groups did not differ significantly in LV dimensions, ejection fraction, or fractional shortening. The LV and RV inflow indices were comparable between the RFA and control groups, except that LV filling velocity during atrial contraction was decreased in the RFA group. The LA and RA volumes (minimum and maximum) and their indices were significantly higher in the RFA group.Table 2Conventional echocardiographic parameters^a^VariableControl groupRFA group postablation*p* ValueNumber2022Age (years)16.3 ± 1.616.6 ± 2.4NSBody surface area (m^2^)1.6 ± 0.141.6 ± 1.86NSBMI (kg/ m^2^)20.69 ± 2.5621.05 ± 2.7NSLV end-diastolic volume (ml)103.5 ± 21.6104.5 ± 20.63NSLV end-systolic volume (ml)23.0 ± 6.824.4 ± 8.7NSLV ejection fraction (%)56.5 ± 3.954.5 ± 3.97NSLV fractional shortening (%)45.3 ± 4.646.4 ± 5.62NSLV myocardial mass index (g/m^2^)86.2 ± 3.690.3 ± 4.5NSLV early filling velocity (cm/s)82.0 ± 12.188.1 ± 7.2NSLV filling velocity during atrial contraction (cm/s)55.4 ± 8.048.2 ± 2.20.01LV early filling deceleration time (ms)162.8 ± 31.9161.4 ± 35.8NSRV basal diameter (mm)28.3 ± 2.329.1 ± 3.2NSRV early filling velocity (cm/s)61.4 ± 12.358.8 ± 11.0NSTricuspid annulus motion amplitude (mm)19.5 ± 0.621.4 ± 0.4NSMaximal LA volume (ml)28.0 ± 8.737.3 ± 13.90.024Maximal LA volume index (ml/m^2^)16.7 ± 6.026.3 ± 9.80.002Maximal RA volume (ml)16.0 ± 6.721.5 ± 8.50.047Maximal RA volume index (ml/m^2^)16.0 ± 6.621.5 ± 8.50.05Minimal LA volume (ml)11.65 ± 2.2513.64 ± 2.250.007Minimal LA volume index (ml/m^2^)7.16 ± 1.38.36 ± 1.320.005Minimal RA volume (ml)12.15 ± 4.515.23 ± 5.010.043Minimal RA volume index (ml/m^2^)7.41 ± 2.529.36 ± 3.20.035*NS* not significant by an independent two-sampled test, *RFA* radiofrequency ablation, *BMI* body mass index, *LV* left ventricular, *RV* right ventricular, *LA* left atrial, *RA* right atrial^a^Values are expressed as mean ± standard deviation

To determine the causes of LA and RA dilation, correlations between atria volume and clinical parameters (age, weight, duration of disease, characteristics of paroxysms of AV tachycardia), HR parameters and functional parameters (LV and RV dimensions and function) were assessed. Correlations were found between the HR mean and the LA/RA maximal volumes (*r* = 0.477, *p* \< 0.001 and *r* = 0.512, *p* \< 0.001, respectively) and minimal volumes (*r* = 0.416, *p* \< 0.001 and *r* = 0.288, *p* \< 0.005, respectively), the LA/RA maximal volume indices (*r* = 0.471, *p* \< 0.001 and *r* = 0.550, *p* \< 0.001, respectively), and the LA/RA minimal volume indices (*r* = 0.434, *p* = 0.004 and *r* = 0.397, *p* = 0.009, respectively).

### Longitudinal Strain and Strain Rate Parameters of the Ventricles and Atria {#Sec14}

All ε and SR tracings were acceptable for the analysis of longitudinal atrial and ventricular ε and SR. The LA and RA longitudinal ε and SR are presented in Table [3](#Tab3){ref-type="table"}. The ε values during atrial contraction were reduced in all the LA and RA wall segments in RFA group. During relaxation, ε was reduced in all the LA and RA wall segments in the RFA group except for the LA middle segments of the inferior and anterior walls. Longitudinal SR during atrial contraction was reduced in all the LA and RA walls in the RFA group except for the middle segments of the RA lateral wall and the LA inferior wall. Longitudinal SR during relaxation was reduced only in the annular segments of LA in the RFA group.Table 3Atrial longitudinal strain and strain rate^a^ParametersContractionRelaxationControl group (*n* = 20)RFA group postablation (*n* = 22)*p* ValueControl group (*n* = 20)RFA group postablation (*n* = 22)*p* Value*A4C*AS annular seg Strain (%)−5.54 (2.0)−2.44 (1.09)\<0.00121.55 (5.97)12.75 (2.87)\<0.001 Strain rate (s^**−**1^)−2.2 (1.25)−1.05 (0.37)0.0011.43 (1.3)1.08 (0.96)0.02AS middle seg Strain (%)−5.57 (2.94)−2.58 (1.6)0.00117.89 (5.12)12.62 (3.68)0.001 Strain rate (s^**−**1^)−1.9 (0.75)−1.25 (0.36)0.0031.86 (0.73)1.66 (0.96)NSLA lateral wall annular seg Strain (%)−5.63 (2.8)−2.82 (1.35)\<0.00123.56 (17.01)10.35 (4.4)0.005 Strain rate (s^**−**1^)−2.32 (0.83)−1.48 (0.5)0.0011.66 (0.44)1.3 (0.58)0.001LA lateral wall middle seg Strain (%)−4.32 (2.3)−2.67 (1.24)0.00119.54 (11.32)9.37 (4.10)0.02 Strain rate (s^**−**1^)−2.14 (0.9)−1.28 (0.26)0.0011.65 (0.32)1.44 (0.5)NSRA lateral wall annular seg Strain (%)−6.67 (1.05)−4.33 (1.6)\<0.00124.02 (10.88)15.39 (5.29)0.006 Strain rate (s^**−**1^)−2.22 (1.8)−1.81 (0.29)0.0031.37 (0.851.31 (0.1)NSRA lateral wall middle seg Strain (%)−5.05 (1.96)−3.55 (2.16)0.0425.75 (14.23)14.66 (5.63)0.03 Strain rate (s^**−**1^)−2.21 (0.3)−2.03 (0.4)NS1.27 (0.52)1.08 (0.19)NS*A2C*LA inferior wall annular seg Strain (%)−4.61 (3.07)−2.04 (1.66)0.00526.09 (17.05)15.62 (3.69)0.02 Strain rate (s^**−**1^)−2.45 (0.5)−1.88 (0.4 2)0.0011.59 (0.1)1.36 (0.26)0.02LA inferior wall middle seg Strain (%)−4.18 (1.2)−2.79 (0.55)\<0.00122.34 (6.08)18.76 (5.37)NS Strain rate (s^**−**1^)−2.42 (0.12)−2.12 (0.71)NS1.54 (0.15)1.41 (0.27)NSLA anterior wall annular seg Strain (%)−4.67 (2.07)−3.11 (1.2)0.01424.14 (11.83)15.08 (3.43)0.005 Strain rate (s^**−**1^)−2.26 (0.77)−1.35 (0.16)0.0421.57 (0.1)1.49 (0.35)NSLA anterior wall middle seg Strain (%)−4.37 (2.57)−2.88 (1.02)0.03819.22 (7.04)15.37 (3.96)NS Strain rate (s^**−**1^)−2.21 (0.74)−1.49 (0.4)0.0021.51 (0.38)1.51 (0.39)NS*A4C* apical four-chamber view, *AS* atrial septum, *seg* segment, *NS* not significant by an independent two-sampled test, *LA* left atrium, *RA* right atrium, *A2C* apical two-chamber view^a^Values are expressed as mean (standard deviation)

There was a negative correlation between maximal LA volume and LA longitudinal SR during relaxation (*r* = --0.476, *p* = 0.03) and a positive correlation between minimal LA volume and both LA longitudinal SR (*r* = 0.361, *p* = 0.03) and ε (*r* = 0.375, *p* = 0.024) during contraction.

Negative correlations were found between HR max and both ε (*r* = --0.518, *p* = 0.05) and SR (*r* = --0.661, *p* = 0.005) during relaxation of the LA lateral wall, and between HR max and SR (*r* = --0.640, *p* = 0.008) during contraction of the atrial septum. The LV and RV longitudinal deformation values were homogeneous for all the LV and RV segments, and there were no significant differences between the subjects of the two groups (Table [4](#Tab4){ref-type="table"}).Table 4Left and right ventricular global longitudinal strain and strain rate (s^**−**1^)^a^ParametersControl group (*n* = 20)RFA group (*n* = 22)*p* ValueLV peak strain (%)−21.55 (3.6)−20.77 (3.8)NSLV peak systolic strain (%)−17.48 (2.04)−18.17 (3.03)NSLV peak systolic strain rate (s^−1^)−1.23 (0.46)−1.32 (0.53)NSLV early diastolic strain rate (s^−1^)1.71 (0.36)1.86 (0.25)NSLV late diastolic strain rate (s^−1^)0.95 (0.43)1.04 (0.29)NSRV peak strain (%)−20.63 (5.43)−20.66 (5.43)NSRV peak systolic strain (%)−17.89 (5.75)−19.54 (5.38)NSRV peak systolic strain rate (s^−1^)−1.33 (0.6)−1.25 (0.65)NSRV early diastolic strain rate (s^−1^)1.81 (0.41)1.67 (0.39)NSRV late diastolic strain rate (s^−1^)1.03 (0.44)0.93 (0.29)NS*LV* left ventricular, *NS* not significant by an independent two-sampled test, *RV* right ventricular^a^Values are expressed as mean (standard deviation)

### Reproducibility of Longitudinal Strain and Strain Rate Measurements {#Sec15}

Because continuous variables were distributed abnormally, parameters were transformed to logarithmic scale. The intraobserver variability with a 95% confidence interval was −0.1 (−0.91 to −0.7) for the atrial systolic longitudinal ε and −0.04 (−0.11 to −0.03) for the atrial longitudinal systolic SR.

Discussion {#Sec16}
==========

The effectiveness of the treatment for supraventricular tachyarrhythmia using RFA in children is high, and the complication rate is low \[[@CR3], [@CR7]\]. Usually, after successfully performed RFA, children have no reports of heart failure. They are considered as healthy and engage in sports activities.

In our study, all the RFA children at the late follow-up assessment were free of paroxysms and did not have any complaints except for eight children (36%), who felt palpitations during their daily activity and presented with episodes of sinus tachycardia that had a mean duration of 1 to 2 min on the Holter 24-h monitoring. Electrophysiologic transesophageal examination did not show inducible supraventricular tachycardia in any of the children during the late follow-up period.

Compared with preablation data, R-R intervals were shorter in all the RFA children at the late follow-up assessment. The 24-h Holter monitoring showed that mean and maximal HR were increased, whereas the HRV parameters, including time domain indices (pNN50, rMSSD) and frequency domain index (HFC), which reflect the attenuation of parasympathetic tone, were decreased in the RFA children during the late postablation period. Echocardiographic examination showed increased atria volumes and reduced regional atrial myocardial deformation parameters (ε and SR), especially in annular segments of the atria, in the RFA children during the late postablation period.

The possible reason for the main findings is that HRV reflects attenuation of the parasympathetic tone and decreased atria function (increased atria volumes and reduced regional atrial myocardial deformation) late after RFA in the children of our study.

Changes in the autonomic tone have been described after fast- and slow-pathway ablation for AV node tachycardia \[[@CR8]--[@CR10], [@CR16]\]. In contrast to previous studies, which have shown changes immediately or the next day after RFA \[[@CR14], [@CR16], [@CR19], [@CR21]\], we found the changes in autonomic tone of the heart during the late follow-up period. Only two other studies have demonstrated changes in autonomic tone during a 6-month to 1-year follow-up period after accessory pathways and AV node slow-pathway RFA \[[@CR8], [@CR10]\].

Previous clinical and experimental studies have provided evidence that postprocedural expansion of myocardial radiofrequency lesions can occur. In an experimental study using young lambs, myocardial scar dimensions were reported to increase in a time-dependent manner up to 9 months after RFA, from 5.3 ± 0.5 mm to 8.7 ± 0.7 mm in atrium tissue and from 5.9 ± 0.8 mm to 10.1 ± 0.7 mm in ventricular tissue \[[@CR15]\]. Moreover, the postinjury remodeling process includes compensatory myocyte hypertrophy in the myocardium remote from the scar \[[@CR13]\]. Radiofrequency-induced lesions not only may directly interrupt anatomically distinct neural fibers, but they also may activate or inhibit reflex cardiac circuits \[[@CR10]\]. Thus, parasympathetic denervation may be an explanation for the increased HR and inappropriate sinus tachycardia in these children. Experimental studies have shown that parasympathetic reinnervation usually requires only 6 weeks (in dogs) \[[@CR14], [@CR16]\]. The possible explanation for the long-term changes in the autonomic tone after RFA may be a more pronounced lesion of RFA in a child heart, which is smaller and has thinner walls more vulnerable to injury.

Our study found correlations between mean HR and atria volumes, between LA volume and regional atrial deformation parameters, and between maximal HR and regional atrial deformation parameters. Correlations between LA volume, regional atrial deformation, and HR permit us to assume that inappropriate adrenergic response, elevated sympathetic tone, and inhomogeneity of parasympathetic innervation in the atria (regional differences in repolarization and conduction velocity) \[[@CR10]\] late after AV node slow-pathway RFA may lead to the development of atrial dilation and dysfunction.

Assessment of regional atrial function using speckle tracking in children may provide more insights into atrial remodeling and may be helpful in many clinical conditions \[[@CR5], [@CR6], [@CR18], [@CR20], [@CR22]\]. To our knowledge, this is the first study to assess atria morphology and regional deformation parameters after RFA of the AV node slow pathway in children.

In conclusion, increased mean and maximal HR, decreased HRV parameters, increased atria volumes, and decreased atria segmental deformation parameters at the late follow-up assessment for children who underwent RFA suggest a possible link between atrial dysfunction and the hyperadrenergic state after AV node slow-pathway RFA. Speckle-tracking echocardiography may be useful in the assessment of atria function in patients who have undergone RFA.

Changes in HRV and in atria function in a pediatric population late after RFA imply certain negative aspects of the RFA procedure. However, the clinical value of this finding has to be evaluated in experimental anatomic and further prospective clinical studies.

Study Limitations {#Sec17}
=================

Our study showed a hyperadrenergic state during the late AV node slow-pathway postablation period, and this finding may be qualified as partial autonomic neuropathy. Neurohumoral activation factors such as catecholamine, plasma natriuretic peptides, rennin activity, and aldosterone levels also are expected to be elevated. However, tests for these factors were not performed, and further investigations are needed.
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